Scrip: industry news and insights
ASCO Data Show A Battle Ahead For Roche And Genmab’s Lymphoma Bispecifics
27 May 2022
Roche looks set to gain first and second place in the race to bring CD3Xcd20s to market – but Genmab...
Following submission of new drug application of Zilretta (FX006) for knee osteoarthritis in mid-December 2016, Flexion Therapeutics CEO Mike Clayman is hoping for priority review of the filing, in addition to fast track status. Zilretta is an extended release formulation of the triamcinolone acetonide. Steroid injection is a common treatment, but pain relief wanes after two to four weeks. Competing against generic steroids, which cost only USD 10–20 per dose, presents a big commercial challenge however. In an interview at Biotech Showcase, Clayman explains the rationale for pricing a long-acting steroid at USD 500 per dose and the company's commercial strategy.
Scrip: industry news and insights
27 May 2022
Roche looks set to gain first and second place in the race to bring CD3Xcd20s to market – but Genmab...
Scrip: industry news and insights
27 May 2022
Recent executive changes in the industry include C-suite changes at Radius Health and Sorrento Therapeutics. Meanwhile, new directors were appointed...
Scrip: industry news and insights
By Joseph Haas 27 May 2022
While a combo regimen of Cabometyx and Tecentriq actually showed a lower response rate in lung cancer than a 2020...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: